# Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

> **NCT01314677** · NA · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Stage IIIA Non-small Cell Lung Cancer

## Interventions

- **PROCEDURE:** positron emission tomography/computed tomography (PET/CT)
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT01314677
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No subjects have been accrued to this trial. The PI will no longer be at COH and requests a study withdrawal/closure.
- **Last updated:** 2012-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314677, "Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01314677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*